Cas:1235475-17-8 methyl 4-amino-6-chloropicolinate manufacturer & supplier

Chemical Name:methyl 4-amino-6-chloropicolinate

CAS.NO:1235475-17-8

Synonyms:2-Pyridinecarboxylic acid,4-amino-6-chloro-,methyl ester;methyl 4-amino-6-chloropicolinate

Molecular Formula:C₇H₇ClN₂O₂

Molecular Weight:186.59600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.384

Index of Refraction:

PSA:65.21000

Exact Mass:186.02000

LogP:1.68500

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Pyridinecarboxylic acid,4-amino-6-chloro-,methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 4-amino-6-chloropicolinate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pyridinecarboxylic acid,4-amino-6-chloro-,methyl ester Use and application,2-Pyridinecarboxylic acid,4-amino-6-chloro-,methyl ester technical grade,usp/ep/jp grade.

Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients. methyl 4-amino-6-chloropicolinate manufacturer In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. methyl 4-amino-6-chloropicolinate supplier But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. methyl 4-amino-6-chloropicolinate vendor In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. methyl 4-amino-6-chloropicolinate factory In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.”